Last update 08 May 2025

OBX02 Series

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
ALK x EGFR
Action
inhibitors, antagonists
Mechanism
ALK inhibitors(Anaplastic lymphoma kinase inhibitors), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Therapeutic Areas
NeoplasmsRespiratory DiseasesNervous System Diseases+ [1]
Active Indication
ALK positive Non-Small Cell Lung CancerEGFR positive non-small cell lung cancerGlioblastoma+ [1]
Inactive Indication-
Originator Organization
Oncobix Co., Ltd.Oncobix Co., Ltd.
Active Organization
Oncobix Co., Ltd.Oncobix Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with OBX02 Series
Login to view more data
100 Translational Medicine associated with OBX02 Series
Login to view more data
100 Patents (Medical) associated with OBX02 Series
Login to view more data
100 Deals associated with OBX02 Series
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ALK positive Non-Small Cell Lung CancerPhase 1
South Korea
Oncobix Co., Ltd.Oncobix Co., Ltd.
-
EGFR positive non-small cell lung cancerPhase 1
South Korea
Oncobix Co., Ltd.Oncobix Co., Ltd.
-
GlioblastomaDiscovery
South Korea
Oncobix Co., Ltd.Oncobix Co., Ltd.
26 Apr 2023
Idiopathic Pulmonary FibrosisDiscovery
South Korea
Oncobix Co., Ltd.Oncobix Co., Ltd.
26 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free